3,4-双(4'-叠氮基呋咱-3'-基)氧化呋咱合成、表征与晶体结构研究

自行设计了3,4-双(4'-叠氮基呋咱-3'-基)氧化呋咱(DAZTF)的分子结构与合成方法,采用3-氨基呋咱-4-酰氯肟为原料,经重氮化、叠氮化、分子间缩合环化等反应合成目标化合物DAZTF,总收率为81%,并采用红外光谱、核磁共振光谱、质谱以及元素分析等进行了结构表征;首次培养了DAZTF单晶,X射线单晶衍射结果表明:DAZTF晶体属于单斜晶系,P2(1)/n空间群,a=1.1620(6)nm,b=0.6977(4)nm,c=1.4446(8)nm,α=90o,β=98.331(9)o,γ=90o,V=1.1589(11)nm3,Z=4,Dc=1.743g/cm3,μ=0.150mm-1,F(000)=608;同时,开展了DAZTF部分性能研究,其熔点50～52℃,分解温度204.20℃,摩擦感度86%～100%(90°摆角),撞击感度86%～100%(10kg,25cm).     

3,4-双（4＇-硝基呋咱-3＇-基）氧化呋咱合成、表征与性能研究

采用丙二腈为原料,经亚硝化、重排、肟化、脱水环化、分子间缩合环化以及氧化等反应合成含能化合物3,4-双（4＇-硝基呋咱-3＇-基）氧化呋咱（DNTF）,总收率为43%,并采用红外光谱、核磁共振光谱、INADEQUATE谱、质谱和元素分析等进行了结构表征.开展了DNTF物化与爆轰性能研究,其密度1.937 g/cm3,熔点109～110℃,爆速8930 m/s（ρ=1.870 g/cm3）,摩擦感度44%～60%（90°摆角）,撞击感度80%～96%（10 kg,25 cm）,特性落高H50为38.9 cm（5 kg）,爆发点315～340℃,爆热5789 J/g（ρ=1.83 g/cm3）,威力168.4%TNT当量,真空安定性（5 g样品,100℃,40 h）放气量1.09 mL.采用DSC法和TG-DTG法测定了DNTF的热稳定性,利用真空安定法研究了DNTF同1,3,5-三硝基-1,3,5-三氮杂环己烷（RDX）,1,3,5,7-四硝基-1,3,5,7-四氮杂环辛烷（HMX）,2,4,6-三硝基甲苯（TNT）及推进剂含能组分的相容性,结果表明：DNTF具有较好的热稳定性,其分解温度为253.56℃;良好的相容性,可与常用含能材料（RDX,HMX,TNT）相容.DNTF能量较高、熔点较低、机械感度适中,安定性好,可作为新一代熔铸混合炸药的液相载体.     

5-取代氧化呋咱并[3,4-b]吡啶衍生物的合成与表征

以廉价易得的2,6-二氯吡啶为原料,经过硝化、叠氮化、热解环化步骤得到中间体[1,2,5]噁二唑并[3,4-e]四唑并[1,5-a]吡啶-3-氧化物(4b),再与浓硫酸/硝酸钾、甲醇钠和甲胺水溶液反应分别得到5-取代的氧化呋咱并[3,4-b]吡啶衍生物5~7。 研究了化合物4b结构的稳定性,发现其中的氧化呋咱环在强酸性、强碱性和弱碱性条件下较稳定,而吡啶环与叠氮基形成的四唑环结构则不太稳定。     

5-甲基-2(1H)吡啶酮的合成

以5-甲基-2-氨基吡啶为起始原料,通过重氮盐水解反应,合成了5-甲基-2(1H)吡啶酮,并对其合成工艺进行了研究,其结构经IR确证。     

4，6－二硝基苯并氧化呋咱的合成

采用新的合成方法，以苦基氯为原料，经过叠氮化和脱氮环化反应，合成了苯并氧化呋咱化合物。对其结构作了理论分析和实验鉴定，认为该化合物具有杂芳结构。     

3,4-二氨基呋咱基氧化呋咱的制备及晶体结构研究

首次通过3-氨基-4-氯肟基呋咱在热作用下脱HCl、[4 2]关环反应制备了新型呋咱(氧化呋咱)类含能化合物3,4-二氨基呋咱基氧化呋咱(DAFF),并培养出了DAFF单晶.用X射线单晶衍射、元素分析和红外光谱对其分子结构进行了表征.测试结果表明:DAFF晶体属三斜晶系,空间群P1,a=0.6400(4)nm,b=1.0609(8)nm,c=1.4634(7)nm,α=83.53(5)°,β=87.27(4)°,γ=77.74(5)°,V=0.9645(11)nm3,Z=4,Dc=1.737g?cm-3,F(000)=512,μ(MoKα)=0.149mm-1;R1=0.0568,wR2=0.1137.DAFF分子不共面,三环面扭曲,面间夹角为27.18(1.99)°和30.48(2.07)°,晶体中存在分子内和分子间氢键.     

5-氯-2-硝基苯胺合成5-氯-苯并氧化呋咱反应的密度泛函研究

利用密度泛函理论(DFT)的B3LYP/6-31G(d,p)计算方法研究了次氯酸钠氧化环化5-氯-2-硝基苯胺合成5-氯-苯并氧化呋咱的反应, 采用连续介质模型(PCM)评估了溶剂效应. 提出两种可能的分步反应通道: (1)氧化、移氢、脱水和环化, (2)移氢、亚氨基氢扭转、氧化、脱水和环化|前者为优势通道. 非极性的CCl₄溶剂有较低的活化能垒, 比极性的乙醇溶剂更有利于5-氯-2-硝基苯胺的合成. 标题反应的机理类似于次氯酸钠氧化邻硝基苯胺合成苯并氧化呋咱, 但其速控步的活化能垒更低, 反应更易进行.     

7-氨基-6-硝基苯并二氧化呋咱的合成和表征

以3,5-二硝基苯甲酸(DNBA)为原料经过3步反应合成了7-氨基-6-硝基苯并二氧化呋咱(ANBDF)：第1步反应,在二氯乙烷惰性溶剂中,DNBA与叠氮酸反应并发生Schmidt重排反应生成3,5-二硝基苯胺(1),产率89．6％;第2步反应,1含100％硫酸的硝硫混酸中硝化生成五硝基苯胺(2),产率51．1％;第3步反应,2与叠氮酸反应,不经分离直接进行热解脱氮、Schmidt重排反应,得到目标化合物(ANBDF),m．p．204℃-206℃,产率86．8％。用元素分析,IR,^1H NMR和MS(FAB)对ANBDF的结构进行了鉴定,确证其分子结构中含有氨基、硝基及苯并氧化呋咱环,这些基团存在于同一个苯环上,且处于同一平面。并对合成反应的机理及反应条件进行了讨论。     

4,6—二硝基苯并氧化呋咱的合成

采用新的合成方法，以苦基氯为原料，经过叠氮化和脱氮环化反应，合成了苯并氧化呋咱化合物。对其结构作了理论分析和实验鉴定，认为该化合物具有杂芳结构。     

3,4-双(3',5'-二硝基苯-1'-基)氧化呋咱的合成

设计并合成了新化合物3,4-双(3',5'-二硝基苯-1'-基)氧化呋咱(4).以苯甲腈为起始原料,经加成、重氮化、分子间二聚得到3,4-二苯基氧化呋咱(3),3经HNO3/H2SO4硝化合成了4,其结构经1H NMR,IR和元素分析表征;初步考察了加成、重氮化、缩合环化、硝化等反应的主要影响因素,确定了适宜的反应条件.     

Synthesis and Characterization of New Thiazolidin-4-one Derivatives

The synthesis of some new functionalized thiazolidin-4-one derivatives has been described. The N-substituted-thiosemicarbazides 3a-3i were obtained though the reaction of alkylamines 2a–2i , carbon disulfide, and hydrazine hydrate. The condensation reaction between 3a–3i and 4-amino-2-methanesulfanylpyrimidine-5-carboxaldehyde 1 afforded the thiosemicarbazones 4a–4i . The corresponding thiazolidin-4-ones 5a–5i were prepared by cyclization of 4a–4i with ethyl bromoacetate. The structures of the final products were confirmed by IR, ¹ H NMR, ¹³ C NMR, and HRMS.     

5-烷氧基-4-环胺基-3-卤-2(5H)-呋喃酮的合成与表征

在氟化钾作用下,亲核试剂环状仲胺与5-烷氧基-3,4二卤-2(5H)-呋喃酮在室温下发生串联的迈克尔加成-消除反应,合成了17个新化合物.通过旋光度,UV-Vis,IR,1H NMR,13C NMR,MS,元素分析和X射线单晶衍射等表征方法,确定了目标化合物的化学结构和绝对构型.     

Preparation and Structure Characterization of 4-Amino-1,2,4-triazol-5-one Hydrate

4-Amino-1,2,4-triazol-5-one hydrate (ATO·H₂O) was prepared and its structure was analyzed by four-circle diffraction measurement. The obtained results show that the crystal belongs to the triclinic crystal system, space group P 1 with crystal parameters a = 6.432(1), b = 6.551(1), c = 6.740(1) ; = 68.04(1), = 82.18(1), = 81.90(1)°, V = 259.7(7) ³; Z = 2; Dc = 1.510 g/cm³; = 0.131 mm^-1; F(000) = 124. ATO·H₂O was characterized by FT-IR analysis, X-ray diffraction analysis, and single crystal diffraction analysis.     

Synthesis of 4-Phenoxytetrahydro-1,3,4λ5-thiazaphosphol-2-one 4-Sulfide

Russian Journal of General Chemistry -     

Synthesis,Spectroscopic Studies and Keto-Enol Tautomerism of Novel 1,3,4-Thiadiazole Derivative Containing 3-Mercaptobutan-2-one and Quinazolin-4-one Moieties

In this study, a novel 1,3,4-thiadiazole derivative containing 3-mercaptobutan-2-one and quinazolin-4-one moieties (Compound 3) is synthesized by the coupling of 2-amino-1,3,4-thiadiazole-5-(3-mercaptobutan-2-one) (Compound 1) with 2-Phenyl-4H-3,1-benzoxazin-4-one (Compound 2) in one molecule moiety. Compound 3 is found to exist as two types of intra-molecular hydrogen bonding with keto-enol tautomerism characters, which is further confirmed using FTIR, ¹H-NMR, ¹³C-NMR, mass spectrometer, and UV-Visible spectra. The ¹H-NMR and UV-Visible spectra of Compound 3 are investigated in different solvents such as methanol, chloroform, and DMSO. Compound 3 exhibits keto-enol tautomeric forms in solvents with different percentage ratios depending on the solvent polarity. The ¹H-NMR and UV-Visible spectral results show that Compound 3 favors the keto over the enol form in polar aprotic solvents such as DMSO and the enol over the keto form in non-polar solvents such as chloroform. The ¹³C-NMR spectrum gives two singles at δ 204.5 ppm, due to ketonic carbon, and δ 155.5 ppm, due to enolic carbon, confirming the keto-enol tautomerism of Compound 3. Furthermore, the molecular ion at m/z 43 and m/z 407 in the mass spectrum of Compound 3 and fragmentation mechanisms proposed reveal the existence of the keto and enol forms, respectively.     

Synthesis of Hexakis-(4-tetrazolylphenyloxy)cyclotriphosphazene and Its Alkylonitrile Derivative

Tetrazoles were introduced into cyclotriphosphazenes to obtain hexakis-(4-tetrazolylphenyloxy)cyclotriphosphazene (2) in good yield (88.9%) by reacting hexakis-(4-cyanophenyloxy)cyclotriphosphazene (1) with sodium azide in N,N-dimethylformamide (DMF) in the presence of NH₄Cl as a catalyst. Its alkylonitrile derivative, hexakis-(4-cyanoethyltetrazolylphenyloxy)cyclotriphosphazene (3), was prepared by the reaction of 2 with acrylonitrile in acetonitrile, using triethylamine as a catalyst.

含腺嘌呤的杯芳烃衍生物的合成、表征及其对核苷碱基的分子识别性质

设计合成了一种新型含腺嘌呤基的杯芳烃衍生物(AC)5,11,17,23-四叔丁基-25, 27-二羟基-26-[1-(9-腺嘌呤)-丙氧基]-28-溴丙氧基杯芳烃, 通过红外光谱、元素分析、核磁共振谱和电喷雾质谱等手段对其进行了表征,确认为目标产物; 并采用紫外分光光度法研究了AC的分子识别作用, 通过测定AC与不同浓度、不同组分的核苷、碱基混合体系的吸光度, 证明了AC对尿嘧啶、尿苷具有分子识别作用, 能从其它核苷或碱基共存的体系中将尿苷或尿嘧啶识别出来.     

5-亚环己基-2-取代氨基咪唑啉酮类化合物的合成及其杀菌活性研究

以环己酮和2-硫代乙内酰脲为起始原料,经Knoevenagel缩合反应制得5-亚环己基-2-硫代咪唑啉-4-酮(1),化合物1在乙醇钠/乙醇体系中与碘甲烷反应得到5-亚环己基-2-甲硫基咪唑啉-4-酮(2),化合物2再与相应的取代苯胺或苄胺在冰醋酸体系中回流制得目标化合物5-亚环己基-2-取代氨基咪唑啉酮3a～3r,它们的化学结构经1H NMR,IR,MS和X-ray单晶衍射确证.5-亚环己基-2-对氯苄氨基咪唑啉酮(3q):Mr=335.83,C16H18ClN3O CH4O,Monoclinic,P2(1)/n,ρ=1.264 g/cm3,F(000)=712,Z=4,a=0.59895(12)nm,b=1.2161(2)nm,c=2.4289(5)nm,β=94.03(3)°.初步生物活性测定结果表明:在50μg/mL浓度下,部分目标化合物均对供试菌种显现出一定的抑制活性,其中5-亚环己基-2-对氟苄氨基咪唑啉酮(3p)对油菜菌核的EC50为24.37μg/mL,3q对辣椒疫霉的EC50为28.68μg/mL.     

Synthesis of 3-methyl-substituted pyrazolotriazolopyrimidin-4-one and pyrazolothiazolopyrimidin-4-one derivatives

As a part of a research on anti-inflammatory analgesic compounds 3-methyl substituted pyrazolotria-zolopyrimidin-4-one and pyrazolothiazolopyrimidin-4-one derivatives were prepared by previously reported procedures. None of the compounds showed improved activity when compared with the previously reported unsubstituted analogs.